Malignant potential of the dysgenetic gonad. II.
D000293:Adolescent; D000728:Androgens / Q000502:physiology; D000818:Animals; D002454:Cell Differentiation; D002648:Child; D012734:Disorders of Sex Development / Q000196:embryology / Q000503:physiopathology; D004407:Dysgerminoma / Q000196:embryology / Q000209:etiology / Q000473:pathology; D004622:Embryo, Mammalian / Q000032:analysis; D004967:Estrogens / Q000502:physiology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000032:analysis; D005854:Germ Cells / Q000502:physiology; D006801:Humans; D007223:Infant; D007986:Luteinizing Hormone / Q000032:analysis; D008297:Male; D009095:Mullerian Ducts / Q000254:growth & development; D010051:Ovarian Neoplasms / Q000196:embryology / Q000209:etiology / Q000473:pathology; D011247:Pregnancy; D013737:Testis / Q000196:embryology; D013997:Time Factors; D014424:Turner Syndrome / Q000150:complications / Q000175:diagnosis / Q000196:embryology
D000728:Androgens; D004967:Estrogens; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone